MN and WI Regional Conference Oct 12-13 early registration

The Minnesota Cancer Registrars Association and Wisconsin Cancer Registrars Association are happy to announce that Early Bird registration is now open for the 2nd Annual MCRA/WCRA Regional Education Conference October 12th and 13th located in Bloomington, MN.  Please see the attached program for further information.

Conference Registration Link

If you have any vendors who are looking to have a booth at the conference, please have them contact me for the vendor registration link.

Jess Klaphake, RHIT, CTR – MCRA Communications │ Cancer Registrar  │ CentraCare Health – Coborn Cancer Center

1900 CentraCare Circle, Suite 1600  │ St. Cloud, MN 56303  │ Phone (320) 229-5199 ext. 70884

Email klaphakej@centracare.com

MCRA_WCRA Regional Conference Program 2017 (1)

Save the Date 10/12/17 and 10/13/17 – MCRA/WCRA Regional conference

MCRA/WCRA 2nd Annual Regional Conference will be held on Thursday Oct. 12th & Friday Oct.13th, 2017 at the Embassy Suites by Hilton Bloomington 2800 American Blvd W., Bloomington, MN 55431

(Just a hop, skip & jump from the Mall of America!)

 On behalf of both organizations we’re pleased to offer this regional meeting to you and HOPE you’ll be able to join us! 

More details on speakers & hotel rates to follow.

 

 

2017 Feb 17, two new job posts

Cancer Registry Manager:  

https://careers-nthrive.icims.com/jobs/16566/cancer-registry-manager/job?mode=view

Our Cancer Registry Managers support the health networks, hospitals, clinical trial/pharmaceutical companies and physician groups that utilize our services to manage the cancer registry, support the cancer program and maintain the cancer registry database and reporting requirements for their organization. You will have the support of more than 50 ODM colleagues across the nation as you lead activities to successfully meet the standards set by the American College of Surgeons/Commission on Cancer such as preparing clients for ACoS surveys, overseeing all medical record analysis, data abstraction and overall data management.

  • Active CTR credential.
  • 3+ years of experience managing in an ACoS/CoC accredited Cancer Program.
  • Abstracting experience in an ACoS/CoC accredited facility.
  • ACoS/CoC survey preparation and extensive knowledge of current CoC Cancer Program Standards, abstracting, case identification, follow-up, and multiple EMR and Cancer Registry software systems.
  • Understanding of statistical analysis report generation and interpretation.
  • Ability to travel, if needed, up to 100%of the time.
  • The company provides remote and travel colleagues with company supplied computer equipment, an annual allotment for required professional dues and reference materials, online learning management tools, educational webinars and ODM Helpdesk/Forum to answer your abstracting questions.

CTR, Remote Specialist:

https://careers-nthrive.icims.com/jobs/15354/ctr%2c-remote-specialist/job?mode=view

Our Cancer Registrars support the health networks, hospitals, clinical trial/pharmaceutical companies and physician groups that utilize our services to manage the cancer registry, support the cancer program and maintain the cancer registry database and reporting requirements for their organization. With nThrive, you will have the support of more than 150 ODM colleagues across the nation as you support activities to successfully meet the standards set by the American College of Surgeons/Commission on Cancer such as helping to prepare clients for ACoS surveys, conducting medical record analysis, data abstraction and overall data management.  nThrive provides remote colleagues with company supplied computer equipment, an annual allotment for required professional dues and reference materials, online learning management tools, educational webinars and ODM Helpdesk/Forum to answer your abstracting questions.

 

********************$1000 Sign on Bonus***************************

 

  • Active CTR credential.
  • 2+ years of abstracting experience in an ACoS/CoC accredited facility, 3+ years preferred.
  • ACoS/CoC survey preparation and extensive knowledge of current CoC Cancer Program Standards, abstracting, case identification, follow-up, and multiple EMR and Cancer Registry software systems.
  • Understanding of statistical analysis report generation and interpretation.

2015 Bylaws Report

WCRA 2015 Bylaws Report

September 22, 2015

There was discussion relating to changing the bylaws back to the previous ones to allow new members to
join the association at any time.

The discussion was tabled to the 2015 Fall meeting.

Respectively submitted,
Pat Recely, Bylaws Chair
Nancy Palmer, Bylaws Committee

NCRA Training Link

Dear Wisconsin Cancer Reporters,

As part of getting ready for the transition from Collaborative Stage to directly-assigned clinical and pathologic Tumor, Nodes, Metastases (TNM) staging and SEER Summary Stage in 2015-2016, the National Cancer Registrars Association (NCRA) is providing free training. For those reporters that are new to cancer registry work and reporters that need a refresher, this is a great opportunity to receive training on the American Joint Committee on Cancer (AJCC) TNM coding and SEER summary stage.

While WCRS never stopped requiring SEER summary stage, these training sessions provide an excellent refresher and additional information since the requirement for benign brain tumor reporting began in 2004.

These training sessions are the educational modules that were presented in May at NCRA’s 2014 annual conference during the CDC National Program of Cancer Registries (NPCR) Education and Training Coordinators’ Workshop. They have been posted on the NCRA website. This link will direct you to the presentations, http://www.cancerregistryeducation.org/tnm-ss-resources .

Presentations include:
Results of the AJCC-NCRA Educational Needs Assessment
The National Transition to Directly Coded Stage
CDC-NPCR Transition to Directly Coded Staging: Overview of Transition Activities
CDC-NPCR Transition to Directly Coded Staging: General Rules SEER SS 2000
CDC-NPCR Transition to Directly Coded Staging: Guidelines for Assigning SS 2000
CDC-NPCR Transition to Directly Coded Staging: General Rules for AJCC
CDC-NPCR Transition to Directly Coded Staging: AJCC – Review of Four Cases

If you do not need CE hours, you can watch these presentations for free by clicking directly on the presentation icon. If you would like to purchase CE hours please fill out the viewing form that is available on ths NCRA website and mail payment and form to:

NCRA
Attn: Store/CCRE CEs
1330 Braddock Place Suite 520
Alexandria, VA 22314 USA

You can also find a link to the presentations on the WCRS website at http://www.dhs.wisconsin.gov/wcrs/reporterinfo/index.htm

Sincerely,

Laura Stephenson
QA Manager
Wisconsin Cancer Reporting System

Collaborative Staging Changes

August 23, 2013

After careful consideration, the American Joint Committee on Cancer AJCC), Centers for Disease Control and Prevention (CDC), the Commission on Cancer (CoC), and the National Cancer Institute (NCI) have determined that it is not feasible to continue support of Collaborative Staging beyond diagnosis year 2015. Beginning with cases diagnosed in 2016 support of Collaborative Stage will cease and CDC, CoC and NCI will transition to direct coding of the AJCC TNM staging. We believe that direct coding of AJCC along with the careful collection of clinically significant biomarkers and prognostic factors will provide our programs with a more precise and stable method for the collection of staging data that is positioned to keep pace with future medical advances. The Canadian Council of Cancer Registries (CCCR) is aware of the forthcoming changes and has started a process to determine how staging will continue in Canada.

2014 and 2015 will be a transition period for all of us. During this transition the Collaborative Stage v2.05 Data Collection System will be used. At the same time the AJCC, CDC, CoC, NCI and CCCR will devote resources and support for training and other activities to ensure the continued collection of high quality data. Training will focus on procedures for directly coding clinical and pathological AJCC T, N, and M and stage group, as well as identifying optimal methods to capture biomarkers and prognostic factors. Although planning for this transition is just beginning we will be depending on the surveillance community, in coordination with NAACCR and NCRA, for expertise and insights into effective training development and delivery; and the needed changes in reporting standards and software as we move forward. Together we will build new processes which will ensure the continued collection of high quality data to inform research based on more meaningful clinical information and improve our ability to support best practices for patient care.